BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8370373)

  • 1. Safety profile of an anti-anginal agent with potassium channel opening activity: an overview.
    Roland E
    Eur Heart J; 1993 Jul; 14 Suppl B():48-52. PubMed ID: 8370373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind comparison of the long-term efficacy of a potassium channel opener and a calcium antagonist in stable angina pectoris.
    Guermonprez JL; Blin P; Peterlongo F
    Eur Heart J; 1993 Jul; 14 Suppl B():30-4. PubMed ID: 8370370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy.
    Krumenacker M; Roland E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S93-102. PubMed ID: 1282184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris.
    Frampton J; Buckley MM; Fitton A
    Drugs; 1992 Oct; 44(4):625-55. PubMed ID: 1281076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina.
    Raftery EB; Lahiri A; Hughes LO; Rose EL
    Eur Heart J; 1993 Jul; 14 Suppl B():35-9. PubMed ID: 8370371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antianginal and anti-ischemic efficacy of nicorandil compared with nifedipine in patients with angina pectoris and coronary heart disease: a double-blind, randomized, multicenter study.
    Ulvenstam G; Diderholm E; Frithz G; Gudbrandsson T; Hedbäck B; Höglund C; Moelstad P; Perk J; Sverrisson JT
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S67-73. PubMed ID: 1282179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A potassium channel opener as monotherapy in chronic stable angina pectoris: comparison with placebo.
    Why HJ; Richardson PJ
    Eur Heart J; 1993 Jul; 14 Suppl B():25-9. PubMed ID: 8370369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nicorandil. An updated review of its use in ischaemic heart disease with emphasis on its cardioprotective effects.
    Markham A; Plosker GL; Goa KL
    Drugs; 2000 Oct; 60(4):955-74. PubMed ID: 11085202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potassium channel activators in vasospastic angina.
    Lablanche JM; Bauters C; McFadden EP; Quandalle P; Bertrand ME
    Eur Heart J; 1993 Jul; 14 Suppl B():22-4. PubMed ID: 8370368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antianginal and anti-ischemic efficacy of nicorandil in comparison with isosorbide-5-mononitrate and isosorbide dinitrate: results from two multicenter, double-blind, randomized studies with stable coronary heart disease patients.
    Döring G
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S74-81. PubMed ID: 1282180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease.
    Suryapranata H
    Eur Heart J; 1993 Jul; 14 Suppl B():16-21. PubMed ID: 8370366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antianginal activity of nicorandil, propranolol and diltiazem with reference to the antianginal mechanism.
    Kinoshita M; Hashimoto K; Ohbayashi Y; Inoue T; Taguchi H; Mitsunami K
    Am J Cardiol; 1989 Jun; 63(21):71J-74J. PubMed ID: 2525330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic and clinical effects of an intravenous potassium channel opener--a review.
    Kato K
    Eur Heart J; 1993 Jul; 14 Suppl B():40-7. PubMed ID: 8370372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of nicorandil and atenolol in stable angina pectoris.
    Hughes LO; Rose EL; Lahiri A; Raftery EB
    Am J Cardiol; 1990 Sep; 66(7):679-82. PubMed ID: 2144705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nicorandil on rest and effort angina unresponsive to combination therapy with a calcium antagonist and oral nitrate.
    Araki H; Hayata N; Matsuguchi T; Nakamura M
    Clin Ther; 1987; 9(2):174-82. PubMed ID: 2952276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind comparison of nicorandil and metoprolol in stable effort angina pectoris.
    Di Somma S; Liguori V; Petitto M; Carotenuto A; Bokor D; de Divitiis O; de Divitiis M
    Cardiovasc Drugs Ther; 1993 Feb; 7(1):119-23. PubMed ID: 8485067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of nicorandil versus propranolol in mild stable angina pectoris of effort: a long-term, double-blind, randomized study.
    Meeter K; Kelder JC; Tijssen JG; Bucx JJ; Henneman JA; Kerker JP; Hugenholtz PG
    J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S59-66. PubMed ID: 1282178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-ischaemic actions of potassium channel openers in experimental myocardial ischaemia/reperfusion injury in dogs.
    Auchampach JA; Gross GJ
    Eur Heart J; 1993 Jul; 14 Suppl B():10-5. PubMed ID: 8370365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicorandil: a potassium channel opening drug for treatment of ischemic heart disease.
    Goldschmidt M; Landzberg BR; Frishman WH
    J Clin Pharmacol; 1996 Jul; 36(7):559-72. PubMed ID: 8844437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicorandil for angina.
    Drug Ther Bull; 1995 Dec; 33(12):89-92. PubMed ID: 8777891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.